{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T22:09:54Z","timestamp":1762034994497,"version":"build-2065373602"},"reference-count":72,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3960\/jslrt.20059","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T22:08:22Z","timestamp":1615759702000},"page":"61-70","source":"Crossref","is-referenced-by-count":7,"title":["Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category"],"prefix":"10.3960","volume":"61","author":[{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan,"},{"name":"Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan,"},{"name":"Department of Hematology, Comprehensive Human Biosciences, University of Tsukuba, Tsukuba, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan,"},{"name":"Department of Hematology, Comprehensive Human Biosciences, University of Tsukuba, Tsukuba, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Graduate School of Medicine and Faculty of Medicine, University of the Ryukyus, Nishihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan,"},{"name":"Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan,"},{"name":"Department of Hematology, Comprehensive Human Biosciences, University of Tsukuba, Tsukuba, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26: 4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"2","unstructured":"2 Swerdllow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC. 2017."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Iqbal J, Wright G, Wang C <i>et al.<\/i> Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014; 123: 2915-2923.","DOI":"10.1182\/blood-2013-11-536359"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 de Leval L, Rickman DS, Thielen C <i>et al.<\/i> The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007; 109: 4952-4963.","DOI":"10.1182\/blood-2006-10-055145"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Piccaluga PP, Agostinelli C, Califano A <i>et al.<\/i> Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest. 2007; 117: 823-834.","DOI":"10.1172\/JCI26833"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Iqbal J, Weisenburger DD, Greiner TC <i>et al.<\/i> Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010; 115: 1026-1036.","DOI":"10.1182\/blood-2009-06-227579"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Huang Y, de Reyni\u00e8s A, de Leval L <i>et al.<\/i> Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood. 2010; 115: 1226-1237.","DOI":"10.1182\/blood-2009-05-221275"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Iqbal J, Weisenburger DD, Chowdhury A <i>et al.<\/i> Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic \u03b3\u03b4 T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011; 25: 348-358.","DOI":"10.1038\/leu.2010.255"},{"key":"9","unstructured":"9 Morris SW, Kirstein MN, Valentine MB <i>et al.<\/i> Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science. 1995; 267: 316-317."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Chiarle R, Simmons WJ, Cai H <i>et al.<\/i> Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005; 11: 623-629.","DOI":"10.1038\/nm1249"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Piccaluga PP, Fuligni F, De Leo A <i>et al.<\/i> Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol. 2013; 31: 3019-3025.","DOI":"10.1200\/JCO.2012.42.5611"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Piccaluga PP, Agostinelli C, Califano A <i>et al.<\/i> Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007; 67: 10703-10710.","DOI":"10.1158\/0008-5472.CAN-07-1708"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Asano N, Suzuki R, Kagami Y <i>et al.<\/i> Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol. 2005; 29: 1284-1293.","DOI":"10.1097\/01.pas.0000173238.17331.6b"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Went P, Agostinelli C, Gallamini A <i>et al.<\/i> Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006; 24: 2472-2479.","DOI":"10.1200\/JCO.2005.03.6327"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 McKinney M, Moffitt AB, Gaulard P <i>et al.<\/i> The Genetic Basis of Hepatosplenic T-cell Lymphoma. Cancer Discov. 2017; 7: 369-379.","DOI":"10.1158\/2159-8290.CD-16-0330"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Moffitt AB, Ondrejka SL, McKinney M <i>et al.<\/i> Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017; 214: 1371-1386.","DOI":"10.1084\/jem.20160894"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Heavican TB, Bouska A, Yu J <i>et al.<\/i> Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019; 133: 1664-1676.","DOI":"10.1182\/blood-2018-09-872549"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Watatani Y, Sato Y, Miyoshi H <i>et al.<\/i> Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019; 33: 2867-2883.","DOI":"10.1038\/s41375-019-0473-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Gayden T, Sepulveda FE, Khuong-Quang DA <i>et al.<\/i> Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018; 50: 1650-1657.","DOI":"10.1038\/s41588-018-0251-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Polprasert C, Takeuchi Y, Kakiuchi N <i>et al.<\/i> Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv. 2019; 3: 588-595.","DOI":"10.1182\/bloodadvances.2018028340"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Nakagawa M, Nakagawa-Oshiro A, Karnan S <i>et al.<\/i> Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2009; 15: 30-38.","DOI":"10.1158\/1078-0432.CCR-08-1808"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kataoka K, Nagata Y, Kitanaka A <i>et al.<\/i> Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015; 47: 1304-1315.","DOI":"10.1038\/ng.3415"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 de Leval L, Gaulard P. Cellular origin of T-cell lymphomas. Blood. 2014; 123: 2909-2910.","DOI":"10.1182\/blood-2014-02-555763"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Quivoron C, Couronn\u00e9 L, Della Valle V <i>et al.<\/i> TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011; 20: 25-38.","DOI":"10.1016\/j.ccr.2011.06.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Couronn\u00e9 L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012; 366: 95-96.","DOI":"10.1056\/NEJMc1111708"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Nguyen TB, Sakata-Yanagimoto M, Asabe Y <i>et al.<\/i> Identification of cell-type-specific mutations in nodal T-cell lymphomas. Blood Cancer J. 2017; 7: e516.","DOI":"10.1038\/bcj.2016.122"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Nguyen TB, Sakata-Yanagimoto M, Nakamoto-Matsubara R <i>et al.<\/i> Double somatic mosaic mutations in TET2 and DNMT3A\u2014origin of peripheral T cell lymphoma in a case. Ann Hematol. 2015; 94: 1221-1223.","DOI":"10.1007\/s00277-015-2332-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Sakata-Yanagimoto M. Multistep tumorigenesis in peripheral T cell lymphoma. Int J Hematol. 2015; 102: 523-527.","DOI":"10.1007\/s12185-015-1738-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Kluin PM. Origin and migration of follicular lymphoma cells. Haematologica. 2013; 98: 1331-1333.","DOI":"10.3324\/haematol.2013.091546"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Lieber MR. Mechanisms of human lymphoid chromosomal translocations. Nat Rev Cancer. 2016; 16: 387-398.","DOI":"10.1038\/nrc.2016.40"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Rodr\u00edguez-Pinilla SM, Atienza L, Murillo C <i>et al.<\/i> Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol. 2008; 32: 1787-1799.","DOI":"10.1097\/PAS.0b013e31817f123e"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Lemonnier F, Couronn\u00e9 L, Parrens M <i>et al.<\/i> Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012; 120: 1466-1469.","DOI":"10.1182\/blood-2012-02-408542"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Sakata-Yanagimoto M, Enami T, Yoshida K <i>et al.<\/i> Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014; 46: 171-175.","DOI":"10.1038\/ng.2872"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Vallois D, Dobay MPD, Morin RD <i>et al.<\/i> Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas. Blood. 2016; 128: 1490-1502.","DOI":"10.1182\/blood-2016-02-698977"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Dobay MP, Lemonnier F, Missiaglia E <i>et al.<\/i> Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica. 2017; 102: e148-e151.","DOI":"10.3324\/haematol.2016.158428"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Wang T, Feldman AL, Wada DA <i>et al.<\/i> GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 2014; 123: 3007-3015.","DOI":"10.1182\/blood-2013-12-544809"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Zhang Y, Zhang Y, Gu W, Sun B. TH1\/TH2 cell differentiation and molecular signals. Adv Exp Med Biol. 2014; 841: 15-44.","DOI":"10.1007\/978-94-017-9487-9_2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014; 41: 529-542.","DOI":"10.1016\/j.immuni.2014.10.004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Amador C, Greiner TC, Heavican TB <i>et al.<\/i> Reproducing the molecular subclassification of peripheral T-cell lymphoma\u2013NOS by immunohistochemistry. Blood. 2019; 134: 2159-2170.","DOI":"10.1182\/blood.2019000779"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Sugio T, Miyawaki K, Kato K <i>et al.<\/i> Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS. Blood Adv. 2018; 2: 2242-2252.","DOI":"10.1182\/bloodadvances.2018018754"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Swerdlow SH, Campo E, Pileri SA <i>et al.<\/i> The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127: 2375-2390.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Manso R, Bellas C, Mart\u00edn-Acosta P <i>et al.<\/i> C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas. Haematologica. 2016; 101: e336-e338.","DOI":"10.3324\/haematol.2016.143768"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Ley TJ, Ding L, Walter MJ <i>et al.<\/i> DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010; 363: 2424-2433.","DOI":"10.1056\/NEJMoa1005143"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Langemeijer SMC, Kuiper RP, Berends M <i>et al.<\/i> Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009; 41: 838-842.","DOI":"10.1038\/ng.391"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Genovese G, K\u00e4hler AK, Handsaker RE <i>et al.<\/i> Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371: 2477-2487.","DOI":"10.1056\/NEJMoa1409405"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Jaiswal S, Fontanillas P, Flannick J <i>et al.<\/i> Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371: 2488-2498.","DOI":"10.1056\/NEJMoa1408617"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Palomero T, Couronn\u00e9 L, Khiabanian H <i>et al.<\/i> Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014; 46: 166-170.","DOI":"10.1038\/ng.2873"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Miyoshi H, Sakata-Yanagimoto M, Shimono J <i>et al.<\/i> RHOA mutation in follicular T-cell lymphoma: clinicopathological analysis of 16 cases. Pathol Int. 2020; 70: 653-660.","DOI":"10.1111\/pin.12981"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Fujisawa M, Sakata-Yanagimoto M, Nishizawa S <i>et al.<\/i> Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma. Leukemia. 2018; 32: 694-702.","DOI":"10.1038\/leu.2017.273"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Zang S, Li J, Yang H <i>et al.<\/i> Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. J Clin Invest. 2017; 127: 2998-3012.","DOI":"10.1172\/JCI92026"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Rohr J, Guo S, Huo J <i>et al.<\/i> Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia. 2016; 30: 1062-1070.","DOI":"10.1038\/leu.2015.357"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Lee SH, Kim JS, Kim J <i>et al.<\/i> A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients. Haematologica. 2015; 100: e505-e507.","DOI":"10.3324\/haematol.2015.133074"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Katzav S. Vav1: A Dr. Jekyll and Mr. Hyde protein - good for the hematopoietic system, bad for cancer. Oncotarget. 2015; 6: 28731-28742.","DOI":"10.18632\/oncotarget.5086"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Abate F, da Silva-Almeida AC, Zairis S <i>et al.<\/i> Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc Natl Acad Sci USA. 2017; 114: 764-769.","DOI":"10.1073\/pnas.1608839114"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Boddicker RL, Razidlo GL, Dasari S <i>et al.<\/i> Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. Blood. 2016; 128: 1234-1245.","DOI":"10.1182\/blood-2016-03-707141"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006; 20: 313-318.","DOI":"10.1038\/sj.leu.2404045"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Huang Y, Moreau A, Dupuis J <i>et al.<\/i> Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009; 33: 682-690.","DOI":"10.1097\/PAS.0b013e3181971591"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Pechloff K, Holch J, Ferch U <i>et al.<\/i> The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med. 2010; 207: 1031-1044.","DOI":"10.1084\/jem.20092042"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Fukumoto K, Sakata-Yanagimoto M, Fujisawa M <i>et al.<\/i> VAV1 mutations contribute to development of T-cell neoplasms in mice. Blood. 2020; 136: 3018-3032.","DOI":"10.1182\/blood.2020006513"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Nguyen TB, Sakata-Yanagimoto M, Fujisawa M <i>et al.<\/i> Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma. Cancer Res. 2020; 80: 1875-1884.","DOI":"10.1158\/0008-5472.CAN-19-2787"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Dierks C, Adrian F, Fisch P <i>et al.<\/i> The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res. 2010; 70: 6193-6204.","DOI":"10.1158\/0008-5472.CAN-08-3719"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Alizadeh AA, Eisen MB, Davis RE <i>et al.<\/i> Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403: 503-511.","DOI":"10.1038\/35000501"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Hans CP, Weisenburger DD, Greiner TC <i>et al.<\/i> Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Scott DW, Mottok A, Ennishi D <i>et al.<\/i> Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. J Clin Oncol. 2015; 33: 2848-2856.","DOI":"10.1200\/JCO.2014.60.2383"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Lemonnier F, Dupuis J, Sujobert P <i>et al.<\/i> Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood. 2018; 132: 2305-2309.","DOI":"10.1182\/blood-2018-04-840538"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Cortes JR, Ambesi-Impiombato A, Couronn\u00e9 L <i>et al.<\/i> RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. Cancer Cell. 2018; 33: 259-273.e7.","DOI":"10.1016\/j.ccell.2018.01.001"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Ng SY, Brown L, Stevenson K <i>et al.<\/i> RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. Blood. 2018; 132: 935-947.","DOI":"10.1182\/blood-2017-11-818617"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Witzig TE, Reeder C, Han JJ <i>et al.<\/i> The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood. 2015; 126: 328-335.","DOI":"10.1182\/blood-2015-02-629543"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Kim SJ, Shin DY, Kim JS <i>et al.<\/i> A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas. Ann Oncol. 2016; 27: 712-718.","DOI":"10.1093\/annonc\/mdv624"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Horwitz SM, Koch R, Porcu P <i>et al.<\/i> Activity of the PI3K-\u03b4,\u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 2018; 131: 888-898.","DOI":"10.1182\/blood-2017-08-802470"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Flinn IW, O\u2019Brien S, Kahl B <i>et al.<\/i> Duvelisib, a novel oral dual inhibitor of PI3K-\u03b4,\u03b3, is clinically active in advanced hematologic malignancies. Blood. 2018; 131: 877-887.","DOI":"10.1182\/blood-2017-05-786566"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Ghione P, Faruque P, Mehta-Shah N <i>et al.<\/i> T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma. Blood Adv. 2020; 4: 4640-4647.","DOI":"10.1182\/bloodadvances.2020002396"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/2\/61_20059\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:23:49Z","timestamp":1622870629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/2\/61_20059\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20059","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2021]]}}}